Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Drdgold (DRD) Cash & Equivalents (2017 - 2025)

Drdgold (DRD) has disclosed Cash & Equivalents for 9 consecutive years, with $71.5 million as the latest value for Q2 2025.

  • Quarterly Cash & Equivalents rose 154.49% to $71.5 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $71.5 million through Jun 2025, up 154.49% year-over-year, with the annual reading at $71.5 million for FY2025, 154.49% up from the prior year.
  • Cash & Equivalents hit $71.5 million in Q2 2025 for Drdgold, up from $28.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $163.0 million in Q2 2022 to a low of $28.1 million in Q2 2024.
  • Historically, Cash & Equivalents has averaged $109.9 million across 5 years, with a median of $132.9 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: tumbled 78.85% in 2024 and later surged 154.49% in 2025.
  • Year by year, Cash & Equivalents stood at $154.2 million in 2021, then rose by 5.71% to $163.0 million in 2022, then dropped by 18.47% to $132.9 million in 2023, then crashed by 78.85% to $28.1 million in 2024, then soared by 154.49% to $71.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for DRD at $71.5 million in Q2 2025, $28.1 million in Q2 2024, and $132.9 million in Q2 2023.